Terante, Fernanda P.

HRN: 16-46-47  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2026
CEFTAZIDIME 1GM (VIAL)
05/03/2026
05/09/2026
IV
2gm
Q8
Cap Mr
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: